Zenas BioPharma’s stock climbed 33% following a positive mid-phase trial readout for its lead candidate, obexelimab, in ...
IBS Software, a global leader in SaaS solutions for the travel industry, announced that Thai Airways International Public ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback